Back to news

Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003

Business Wire•05/08/2026•08:00 ET
0
Whiz Insights

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in